Department of Medicine
-
June 15, 2023
New treatment option for metastatic colorectal cancer prolongs survival
Research conducted at Vanderbilt points to a new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options. -
June 15, 2023
Virtual support group helps people with Long COVID
In addition to receiving her medical care at Vanderbilt University Medical Center, Kate Whitley is one of about 100 patients participating in a free virtual support group program for those with Long COVID at VUMC. -
June 14, 2023
NIH grant boosts international TB research consortium
A new grant will help support Vanderbilt's RePORT Brazil, one of an international consortium’s six regional tuberculosis research programs. -
June 13, 2023
Maternal diet influences postnatal diabetes risk
Studies in a primate animal model suggest that islet hyperfunction — which in humans is associated with increased fat mass and Type 2 diabetes — is programmed in offspring by a maternal Western-style diet during pregnancy. -
June 8, 2023
Targeting calcium handling in A-fib
The drug ent-verticilide reduced A-fib incidence and duration in an animal model, suggesting it may be a viable therapeutic option. -
June 5, 2023
Study discovers that tumor mutation burden predicts survival outcome
The expected course of a patient's cancer prognosis has traditionally been judged by its type, stage and microscopic aggressiveness, but patients with the same presentation can still have widely divergent outcomes. Researchers from Vanderbilt-Ingram Cancer Center have discovered that differences in tumor mutation burden are a major reason for this divergence. -
June 5, 2023
Vanderbilt mourns loss of renowned clinical pharmacologist Jackson Roberts II, MD
Jackson Roberts II, MD, an internationally known clinical pharmacologist in the Vanderbilt University School of Medicine who helped define the role of lipid peroxidation and oxidative stress in human disease, died May 31 in Nashville. He was 79.